<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Overview of the chronic neurologic complications of alcohol</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Overview of the chronic neurologic complications of alcohol</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Overview of the chronic neurologic complications of alcohol</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael E Charness, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael J Aminoff, MD, DSc</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Janet L Wilterdink, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 28, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Acute alcohol intoxication is associated with a number of complications including accidents, traffic fatalities, domestic violence, homicide, and suicide. Alcohol dependence is also a chronic disease, associated with malnutrition, trauma, and a wide variety of central nervous system disorders. The chronic neurologic complications of chronic alcohol use disorder are reviewed here. The alcohol withdrawal syndromes are discussed separately. (See  <a class="medical medical_review" href="/d/html/323.html" rel="external">"Management of moderate and severe alcohol withdrawal syndromes"</a>.)</p><p>Wernicke-Korsakoff syndrome is the best known neurologic complication of <a class="drug drug_general" data-topicid="9988" href="/d/drug information/9988.html" rel="external">thiamine</a> (vitamin B1) deficiency [<a href="#rid1">1</a>]. The term refers to two different syndromes, each representing a different stage of the disease. Wernicke encephalopathy (WE) is an acute syndrome requiring emergent treatment to prevent death and neurologic morbidity. Korsakoff syndrome (KS) refers to a chronic neurologic condition that usually occurs as a consequence of WE.</p><p class="headingAnchor" id="H2"><span class="h1">WERNICKE ENCEPHALOPATHY</span><span class="headingEndMark"> — </span>Wernicke encephalopathy (WE) is a common, acute neurologic disorder caused by <a class="drug drug_general" data-topicid="9988" href="/d/drug information/9988.html" rel="external">thiamine</a> deficiency [<a href="#rid1">1</a>]. It is manifested by a clinical triad of encephalopathy, oculomotor dysfunction, and gait ataxia.</p><p>This disorder is discussed in more detail elsewhere. (See  <a class="medical medical_review" href="/d/html/4818.html" rel="external">"Wernicke encephalopathy"</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">KORSAKOFF SYNDROME</span><span class="headingEndMark"> — </span>Korsakoff syndrome (KS) is a late neuropsychiatric manifestation of Wernicke encephalopathy (WE) in which there is a striking disorder of selective anterograde and retrograde amnesia. Although this memory disorder can occur in a variety of conditions that damage the medial temporal lobes, KS is seen most frequently in individuals with alcohol use disorder after an episode of WE, and most patients with KS show typical WE lesions [<a href="#rid1">1</a>]. Any condition that can lead to <a class="drug drug_general" data-topicid="9988" href="/d/drug information/9988.html" rel="external">thiamine</a> loss and WE can also be a cause of KS. (See  <a class="medical medical_review" href="/d/html/4818.html" rel="external">"Wernicke encephalopathy", section on 'Clinical course and prognosis'</a> and  <a class="medical medical_review" href="/d/html/4818.html" rel="external">"Wernicke encephalopathy", section on 'Associated conditions'</a>.)</p><p>In some individuals with alcohol use disorder, KS develops without a recognized acute episode of WE, although typical WE lesions may be present at autopsy [<a href="#rid1">1-3</a>]. It has been suggested that in these cases, KS may result from a series of subclinical or unrecognized episodes of WE.</p><p>Approximately 80 percent of individuals with alcohol use disorder recovering from classic WE exhibit the selective memory disturbance of KS. By contrast, KS is a less frequent sequela of WE that is not associated with alcohol use disorder [<a href="#rid4">4</a>], an observation that suggests that ethanol neurotoxicity is a contributing factor [<a href="#rid5">5</a>]. However, it is also clear that KS can occur in the absence of ethanol ingestion [<a href="#rid5">5-11</a>].</p><p class="headingAnchor" id="H4"><span class="h2">Clinical features</span><span class="headingEndMark"> — </span>KS is characterized by marked deficits in anterograde and retrograde memory, apathy, an intact sensorium, and relative preservation of long-term memory and other cognitive skills [<a href="#rid1">1,12</a>]. Confabulation is a feature in some but not all cases. Attention and social behavior are relatively preserved. Affected subjects are able to carry on a socially appropriate conversation that may seem normal to an unsuspecting spectator. Patients with KS are as a rule unaware of their illness.</p><p>Memory impairment correlates better with lesions in the anterior thalamus rather than mamillary bodies [<a href="#rid13">13</a>]. Nonetheless, atrophy of the mamillary bodies is a relatively specific sign of prior WE, and the finding of small mamillary bodies in a patient with dementia should raise the possibility that alcohol use disorder and malnutrition have contributed to the dementia. Other areas of disproportionate focal volume loss on magnetic resonance imaging (MRI) that appear to be relatively specific for KS include the medial thalami and corpus callosum [<a href="#rid14">14</a>]. (See  <a class="medical medical_review" href="/d/html/4818.html" rel="external">"Wernicke encephalopathy", section on 'Imaging studies'</a>.)</p><p>Some individuals with alcohol use disorder and WE lesions exhibit a more global abnormality of higher cognitive function [<a href="#rid15">15</a>]. One group identified WE lesions at autopsy in 20 patients with alcohol use disorder who had been evaluated by psychiatrists during the course of their illness [<a href="#rid16">16</a>]. Fifteen of the 20 patients were felt to have a global dementia, and only five had a circumscribed memory disorder; KS was diagnosed in only three patients and Alzheimer disease (AD) in eight. Twelve of 15 patients diagnosed with dementia showed only the lesions of WE at autopsy, although subtle structural abnormalities were not sought.</p><p>The occurrence of global dementia in some patients with KS and the absence of non-WE lesions in some individuals with alcohol use disorder and dementia have led some investigators to conclude that most cases of dementia in these patients are nutritional in origin [<a href="#rid1">1,16,17</a>]. However, other mechanisms including ethanol toxicity, stroke, and head trauma should also be considered as playing a role in these patients. (See <a class="local">'Ventricular enlargement and cognitive dysfunction'</a> below.)</p><p class="headingAnchor" id="H5"><span class="h2">Treatment and prognosis</span><span class="headingEndMark"> — </span>Patients with KS rarely recover. Many patients require at least some form of supervision and social support, either at home or in a chronic care facility [<a href="#rid18">18</a>]. There are anecdotal reports of improvement in attention and memory with the use of acetylcholinesterase inhibitors and <a class="drug drug_general" data-topicid="10131" href="/d/drug information/10131.html" rel="external">memantine</a> [<a href="#rid19">19-21</a>], but there is no controlled study.</p><p class="headingAnchor" id="H6"><span class="h1">VENTRICULAR ENLARGEMENT AND COGNITIVE DYSFUNCTION</span><span class="headingEndMark"> — </span>Approximately 50 to 70 percent of individuals with alcohol use disorder have cognitive deficits on neuropsychological testing [<a href="#rid22">22</a>]. Imaging tests, neuropathological observations, and animal studies suggest that ethanol neurotoxicity may contribute to this cognitive dysfunction. Nevertheless, there is no unequivocal evidence for a brain lesion in humans that is caused solely by chronic ethanol ingestion and that is unrelated to coexisting nutritional deficiency, liver disease, or trauma [<a href="#rid1">1,23,24</a>].</p><p>Computed tomography (CT) and magnetic resonance imaging (MRI) show enlargement of the cerebral ventricles and sulci in the majority of individuals with alcohol use disorder. However, when corrected for the effects of aging, the radiographic indices do not correlate consistently with either the duration of drinking or the severity of cognitive impairment [<a href="#rid1">1</a>]. The ventricles and sulci become significantly smaller within approximately one month of abstinence [<a href="#rid25">25-28</a>], while brain water, estimated by MRI or chemical analysis, does not consistently change [<a href="#rid27">27,29,30</a>]. Based upon these findings, it has been hypothesized that changes in brain parenchyma, but not brain water, may account for the reversible radiographic and cognitive abnormalities of individuals with unhealthy alcohol use [<a href="#rid26">26,27,31</a>].</p><p>There is evidence for regional vulnerability in the brains of individuals with unhealthy alcohol use [<a href="#rid32">32</a>]. Neuronal density in the superior frontal cortex was reduced by 22 percent in such individuals compared with controls in one report [<a href="#rid33">33</a>]. Selective loss of neurons in frontal brain regions is mirrored by regional hypometabolism on positron emission tomography (PET) studies [<a href="#rid34">34,35</a>] and might correlate with deficits in working memory that have been observed [<a href="#rid32">32</a>].</p><p>Quantitative morphometry suggests that individuals with unhealthy alcohol use, including those with liver disease and Wernicke encephalopathy (WE), lose a disproportionate amount of subcortical white matter compared with cortical gray matter [<a href="#rid14">14,32,36-38</a>]. The loss of cerebral white matter is evident across a wide range of ages, is not accentuated in the frontal lobes, and is of sufficient magnitude to account for the associated ventricular enlargement [<a href="#rid39">39</a>]. Diffusion-tensor imaging detects microstructural abnormalities in the white matter tracts even in the absence of macroscopic lesions [<a href="#rid40">40</a>]. MRIs show an increase in white matter volume following three months of abstinence, suggesting that a component of the white matter injury is reversible [<a href="#rid41">41,42</a>]. Regional white matter recovery patterns with alcohol abstinence may be modified by cigarette smoking [<a href="#rid42">42</a>].</p><p>Magnetic resonance spectroscopy studies have also found metabolic as well as morphologic evidence of brain recovery occurring within two months of sobriety [<a href="#rid31">31,41</a>]. Thus, it is important to determine whether patients with undiagnosed cognitive decline have problematic alcohol use, because abstinence and nutritional repletion may prevent further worsening.</p><p class="headingAnchor" id="H7"><span class="h1">ALCOHOLIC CEREBELLAR DEGENERATION</span><span class="headingEndMark"> — </span>Some individuals with alcohol use disorder develop a chronic cerebellar syndrome related to the degeneration of Purkinje cells in the cerebellar cortex [<a href="#rid43">43</a>]. Midline cerebellar structures, especially the anterior and superior vermis, are predominantly affected, a pattern identical to that in Wernicke encephalopathy (WE). Alcoholic cerebellar degeneration typically occurs only after 10 or more years of excessive ethanol use.</p><p class="headingAnchor" id="H8"><span class="h2">Pathogenesis</span><span class="headingEndMark"> — </span>Alcoholic cerebellar degeneration may be caused by a combination of nutritional deficiency and alcohol neurotoxicity. A role for nutritional deficiency is suggested by observations that many patients with the disorder are malnourished, and symptom onset has been reported in some patients during periods of abstinence [<a href="#rid1">1</a>]. In addition, identical cerebellar lesions have been observed in a patient who developed WE associated with malnutrition in the absence of excessive alcohol use, suggesting that alcohol was not required for the development of the cerebellar lesion [<a href="#rid44">44</a>].</p><p>One group assessed nutritional status and estimated recent and lifetime alcohol consumption in individuals with alcohol use disorder and controls [<a href="#rid45">45</a>]. Cerebellar volume, determined by magnetic resonance imaging (MRI), was progressively smaller in individuals with alcohol use disorder who were well-nourished, were poorly nourished, or had WE. Regression analysis suggested that both malnutrition and alcohol ingestion (daily intake of more than 140 g of alcohol over 10 years) contributed independently to the development of cerebellar shrinkage. It is noteworthy that individuals with WE reported higher daily ethanol consumption than asymptomatic individuals with alcohol use disorder [<a href="#rid46">46</a>]; thus, it is possible that alcohol intake is a covariate of nutritional deficiency. Other studies have reported conflicting results as to the effect of years of drinking, amount of drinking, and binge drinking on the severity of alcoholic cerebellar degeneration [<a href="#rid47">47,48</a>].</p><p class="headingAnchor" id="H9"><span class="h2">Clinical features</span><span class="headingEndMark"> — </span>Alcoholic cerebellar degeneration usually develops gradually over weeks to months, but it may also evolve over years or commence abruptly. Mild and apparently stable cases can become suddenly worse. Almost all patients complain first of gait impairment, which is typically characterized as weakness, unsteadiness, or incoordination in the legs [<a href="#rid43">43</a>]. Later, a minority of patients may note incoordination and tremor in the arms, dysarthria, and intermittent diplopia or blurred vision. Vertigo, tinnitus, and deafness have not been reported.</p><p>The physical examination in patients with alcoholic cerebellar degeneration demonstrates features of a midline cerebellar lesion, with selective abnormalities of stance, gait, and lower extremity coordination. Patients exhibit ataxia of stance and gait, resembling that of acute alcohol intoxication. Tandem walking is typically impossible, even for those with mild disease. Heel-knee-shin testing is usually abnormal, but finger-nose testing may reveal only mild abnormalities, often associated with more severe impairment of handwriting. Mild dysarthria, characterized as slow, slurred speech, can occur. Some patients also have a coarse, rhythmic, 3 to 5 Hz postural tremor affecting the fingers, arms, or thighs. Cognitive function is usually unimpaired, except in patients with prior episodes of WE.</p><p>The clinical course of alcoholic cerebellar degeneration was characterized in 46 patients in the original series reporting the disorder [<a href="#rid43">43</a>]. In general, progression was associated with continued drinking and stabilization with abstinence. In one-half, symptoms appeared and became maximal over a period of weeks to months and then remained stable during many years of abstinence and improved nutrition. Another 16 declined gradually and progressively over many years of continued drinking. A small number exhibited mild, stable symptoms that worsened abruptly with intercurrent illness or malnutrition. Gait did not improve in most patients, and recovery was partial in those who did improve.</p><p class="headingAnchor" id="H10"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>Sedative hypnotic drug intoxication may be indistinguishable from alcoholic cerebellar degeneration, except for its reversibility. Consequently, some abstinent patients are mistakenly believed to be intoxicated.</p><p>The absence of cranial nerve abnormalities differentiates alcoholic cerebellar degeneration from vascular disorders of the posterior circulation, mass lesions, and demyelinative disease. The age of onset and clinical course set this disorder apart from some of the spinocerebellar ataxias; multiple system atrophy, including olivopontocerebellar degeneration, may be difficult to distinguish on clinical grounds alone.</p><p class="headingAnchor" id="H11"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>The diagnosis of alcoholic cerebellar ataxia is based primarily on the clinical history and neurologic examination, although a structural imaging study should be obtained to rule out mass lesions or other diagnoses. Computed tomography (CT) or MRI scans may show cerebellar cortical atrophy, but one-half of patients with this finding are not ataxic on examination [<a href="#rid49">49</a>]. Whether these represent subclinical cases in which symptoms will develop subsequently is unclear. Prominent atrophy of the anterior vermis of the cerebellum may help distinguish alcoholic cerebellar degeneration from degenerative conditions that may show more diffuse atrophy [<a href="#rid50">50</a>].</p><p>By contrast, PET studies demonstrate a reduction in cerebral metabolic rate for glucose and a decrease in benzodiazepine receptor binding in the superior cerebellar vermis in individuals with alcohol use disorder with cerebellar degeneration compared with those without the disorder [<a href="#rid35">35,51</a>]. The magnitude of hypometabolism correlates significantly with the severity of neurologic deficits. However, positron emission tomography (PET) scanning is a research tool and is not indicated for the diagnosis of patients with suspected alcoholic cerebellar degeneration.</p><p class="headingAnchor" id="H12"><span class="h2">Treatment</span><span class="headingEndMark"> — </span>Cessation of drinking and nutritional supplementation are the only treatments available for alcoholic cerebellar degeneration. However, gait does not improve in most patients [<a href="#rid43">43</a>]. Physical therapy, canes, walkers, and wheelchairs are helpful in maintaining mobility.</p><p>The effect of abstinence was demonstrated in a study that used posturography in a group of 17 individuals with alcohol use disorder with cerebellar degeneration [<a href="#rid52">52</a>]. Neurologic examination revealed ataxia of stance and gait, ataxia on knee-heel test, and minimal abnormalities on finger-nose test. Most showed a 3 Hz tremor in the anteroposterior direction, which was accentuated by eye closure. All were tested five days after detoxification and an average of 18.5 months later. Eleven who remained abstinent showed significant improvements in sway path, sway area, and anteroposterior sway during eye closure; by contrast, six who continued to drink showed worsening of postural instability.</p><p class="headingAnchor" id="H13"><span class="h1">MARCHIAFAVA-BIGNAMI DISEASE</span><span class="headingEndMark"> — </span>Marchiafava-Bignami disease is a rare disorder of demyelination or necrosis of the corpus callosum and adjacent subcortical white matter that occurs predominantly in patients with unhealthy alcohol use who are malnourished [<a href="#rid53">53</a>]. In some cases, there are associated lesions of Wernicke encephalopathy (WE) as well as selective neuronal loss and gliosis in the third cortical layer. A few cases have been described in non-alcohol users, suggesting that alcohol alone is not responsible for the lesion.</p><p>The course of the disease may be acute, subacute, or chronic and is marked by dementia, spasticity, dysarthria, and inability to walk. Patients may lapse into coma and die, survive for many years with dementia, or occasionally recover. An interhemispheric disconnection syndrome has been reported in survivors [<a href="#rid54">54</a>].</p><p>Lesions appear as hypodense areas in portions of the corpus callosum on computed tomography (CT) and as discrete or confluent areas of decreased T1 signal and increased T2 signal on magnetic resonance imaging (MRI) [<a href="#rid55">55</a>]. Individuals with alcohol use disorder without liver disease, amnesia, or cognitive dysfunction show thinning of the corpus callosum at autopsy [<a href="#rid56">56</a>] and on MRI [<a href="#rid57">57,58</a>], suggesting that alcohol or malnutrition damages the corpus callosum commonly in the absence of the necrotic lesions of Marchiafava-Bignami disease. These findings raise the possibility that aggressive nutritional supplementation along with a reduction in drinking can prevent the development of Marchiafava-Bignami disease in individuals with alcohol use disorder.</p><p class="headingAnchor" id="H14"><span class="h1">NEUROMUSCULAR COMPLICATIONS</span></p><p class="headingAnchor" id="H15"><span class="h2">Peripheral neuropathy</span><span class="headingEndMark"> — </span>Individuals with alcohol use disorder have a high incidence of peripheral nerve disorders, including symmetric polyneuropathy, autonomic neuropathy, and compression mononeuropathies. As an example, peripheral neuropathy was detected in 32 percent and autonomic neuropathy in 24 percent of 107 consecutively examined patients in one report [<a href="#rid59">59</a>]. The majority of patients in this series were middle class working men, and evidence of malnutrition was present in only a small minority [<a href="#rid60">60</a>]. The prevalence of autonomic and peripheral neuropathy each correlated best with lifetime alcohol consumption more than with nutritional deficiency [<a href="#rid59">59,61,62</a>].</p><p class="headingAnchor" id="H16"><span class="h3">Pathogenesis</span><span class="headingEndMark"> — </span>Detailed neuropathologic and electrophysiologic evaluation suggests that alcoholic peripheral neuropathy is primarily an axonal neuropathy, complicated by demyelination when there is coexisting nutritional deficiency [<a href="#rid63">63</a>]. Consistent with these findings, studies have found a predominant reduction in the density of small myelinated and unmyelinated fibers in a group of individuals with alcohol use disorder with normal <a class="drug drug_general" data-topicid="9988" href="/d/drug information/9988.html" rel="external">thiamine</a> status, a distinctly different pattern from that of beriberi neuropathy [<a href="#rid64">64,65</a>]. In some studies, the degree of slowing in nerve conduction in alcoholic peripheral neuropathy correlated with reductions in erythrocyte transketolase activity, a marker of thiamine deficiency [<a href="#rid66">66,67</a>]. Taken together, these data suggest that alcoholic peripheral neuropathy is caused by alcohol neurotoxicity, but it is sometimes complicated by vitamin deficiency.</p><p class="headingAnchor" id="H17"><span class="h3">Clinical features</span><span class="headingEndMark"> — </span>Alcoholic polyneuropathy is a gradually progressive disorder of sensory, motor, and autonomic nerves. The clinical abnormalities are usually symmetric and predominantly distal. Symptoms include numbness, paresthesia, burning dysesthesia, pain, weakness, muscle cramps, and gait ataxia. The most common neurologic signs are loss of tendon reflexes, beginning with the ankle jerks, defective perception of touch and vibration sensation, and weakness. Loss of vibratory sensation can be demonstrated in asymptomatic individuals with alcohol use disorder [<a href="#rid68">68</a>].</p><p>Alcoholic polyneuropathy also renders patients susceptible to compression of peripheral nerves at common sites of entrapment, including the median nerve at the carpal tunnel, the ulnar nerve at the elbow, and the peroneal nerve at the fibular head [<a href="#rid69">69</a>]. "Saturday night palsies" occur during bouts of intoxication when the radial nerve is compressed against the spiral groove of the humerus. (See  <a class="medical medical_review" href="/d/html/5282.html" rel="external">"Overview of upper extremity peripheral nerve syndromes"</a>.)</p><p class="headingAnchor" id="H18"><span class="h3">Treatment</span><span class="headingEndMark"> — </span>Specific treatments for alcoholic peripheral neuropathy are not available. Patients should receive <a class="drug drug_general" data-topicid="9988" href="/d/drug information/9988.html" rel="external">thiamine</a> supplementation since malnutrition may contribute to the development of the disorder. Improved nutrition and cessation of drinking have been associated with symptom improvement in cohort studies [<a href="#rid70">70-73</a>], although complete recovery from severe neuropathy is uncommon. Low doses of tricyclic antidepressants, <a class="drug drug_general" data-topicid="9648" href="/d/drug information/9648.html" rel="external">mexiletine</a> [<a href="#rid74">74</a>], or <a class="drug drug_general" data-topicid="8483" href="/d/drug information/8483.html" rel="external">gabapentin</a> are sometimes effective in controlling the burning dysesthesias of alcoholic peripheral neuropathy. (See  <a class="medical medical_review" href="/d/html/5284.html" rel="external">"Overview of polyneuropathy", section on 'Treatment of symptoms and prevention of complications'</a>.)</p><p class="headingAnchor" id="H19"><span class="h2">Myopathy</span><span class="headingEndMark"> — </span>Skeletal myopathy is an underrecognized complication of alcohol use disorder. In two different studies, almost one-half of patients with unhealthy alcohol use visiting an ambulatory clinic and 60 percent of hospitalized patients had biopsy evidence of myopathy [<a href="#rid75">75,76</a>].</p><p>Skeletal muscle can be damaged by the administration of alcohol to well-nourished volunteers [<a href="#rid77">77</a>], and most patients with alcoholic myopathy are not demonstrably malnourished [<a href="#rid62">62,78</a>]. Electrolyte abnormalities such as hypokalemia, which are often present in patients with alcohol use disorder, can also impair skeletal muscle function. However, studies of patients and rats with alcoholic myopathy show no correlation between hypokalemia and muscle damage [<a href="#rid79">79</a>].</p><p>Alcoholic myopathy may present as either an acute, necrotizing disorder or as a more indolent process [<a href="#rid76">76,80</a>]. (See  <a class="medical medical_review" href="/d/html/5166.html" rel="external">"Drug-induced myopathies", section on 'Alcohol'</a>.)</p><p class="headingAnchor" id="H20"><span class="h3">Acute myopathy</span><span class="headingEndMark"> — </span>The acute form develops over hours to days, often in relation to a binge, and is characterized by weakness, pain, tenderness, and swelling of affected muscles. Animal studies suggest that fasting during a binge may precipitate muscle injury [<a href="#rid81">81</a>]. The vast majority of affected patients are men.</p><p>Proximal muscles are often most severely involved, but the distribution of involvement can be asymmetric or focal. Dysphagia [<a href="#rid82">82</a>] and congestive heart failure may occur [<a href="#rid83">83,84</a>]. Laboratory findings include moderate to severe elevation of serum creatine kinase (CK), myoglobinuria, fibrillations, and myopathic changes in the electromyogram, and muscle fiber necrosis on biopsy [<a href="#rid76">76,80,83,85</a>].</p><p>Initial treatment is directed at correcting cardiac arrhythmias, renal failure due to rhabdomyolysis, and electrolyte disturbances such as hypophosphatemia or hypokalemia. Abstinence from ethanol is usually associated with gradual, often partial, recovery [<a href="#rid86">86,87</a>].</p><p class="headingAnchor" id="H21"><span class="h3">Chronic myopathy</span><span class="headingEndMark"> — </span>Chronic alcoholic myopathy, which evolves over weeks to months, is a more common disorder [<a href="#rid62">62,76,78</a>]. Pain is less prominent than in acute alcoholic myopathy, but muscle cramps may occur.</p><p>On examination, the major findings are muscle weakness and atrophy, which affect predominantly the hip and shoulder girdles. Although a polyneuropathy coexists in many cases, the clinical and laboratory features of this disorder indicate a primary disturbance of muscle. Serum CK is less elevated than in acute alcoholic myopathy, and myoglobinuria does not occur.</p><p>Cessation of drinking leads to improvement in most cases, while continued alcohol use results in clinical deterioration [<a href="#rid87">87</a>].</p><p class="headingAnchor" id="H7764398"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Wernicke encephalopathy</strong> – Wernicke encephalopathy (WE) is an acute neurologic disorder caused by <a class="drug drug_general" data-topicid="9988" href="/d/drug information/9988.html" rel="external">thiamine</a> deficiency and manifested by a clinical triad of encephalopathy, oculomotor dysfunction, and gait ataxia. (See  <a class="medical medical_review" href="/d/html/4818.html" rel="external">"Wernicke encephalopathy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Korsakoff syndrome</strong> – Korsakoff syndrome (KS) is a late neuropsychiatric manifestation of WE in which there is a striking disorder of selective anterograde and retrograde amnesia. This syndrome is seen most frequently in individuals with alcohol use disorder after an episode of WE; most patients have neuropathologic evidence of WE. (See <a class="local">'Korsakoff syndrome'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cognitive impairment</strong> – Cognitive impairment is evident on neuropsychological testing in 50 to 70 percent of individuals with alcohol use disorder. Neuroimaging typically shows ventricular and sulcal enlargement that does not clearly correlate with the severity or duration of alcohol use or the degree of cognitive impairment. Some recovery may be possible with abstinence and nutritional repletion. (See <a class="local">'Ventricular enlargement and cognitive dysfunction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Alcoholic cerebellar degeneration</strong> – Alcoholic cerebellar degeneration typically occurs only after 10 or more years of excessive alcohol use and is pathologically manifest by degeneration of Purkinje cells in midline cerebellar structures. Abnormal stance and gait usually develop slowly but can sometimes appear or worsen more abruptly. Abstinence may prevent worsening. (See <a class="local">'Alcoholic cerebellar degeneration'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Marchiafava-Bignami disease</strong> – Marchiafava-Bignami disease is a rare disorder of demyelination or necrosis of the corpus callosum and adjacent subcortical white matter that occurs predominantly in malnourished patients with alcohol use disorder. Dementia, spasticity, dysarthria, and inability to walk may present as an acute, subacute, or chronic condition. Characteristic lesions are seen on magnetic resonance imaging (MRI). (See <a class="local">'Marchiafava-Bignami disease'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neuropathy</strong> – A symmetric polyneuropathy and an autonomic neuropathy are commonly seen in individuals with alcohol use disorder. These patients are also vulnerable to compression neuropathies. Nutritional deficits, as well as alcohol toxicity, may contribute to the pathogenesis. (See <a class="local">'Peripheral neuropathy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Myopathy</strong> – Alcoholic myopathy may present as either an acute, necrotizing disorder or as a more indolent process. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The acute form may occur in relation to a binge and is associated with pain as well as weakness with moderate to severe elevation of creatine kinase (CK) and fibrillations and myopathic changes on electromyography. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Chronic myopathy is less likely to be painful and laboratory findings are less marked. Abstinence is associated with improvement in both settings. (See <a class="local">'Myopathy'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Victor, M, Adams, RA, Collins, GH. The Wernicke-Korsakoff syndrome and related disorders due to alcoholism and malnutrition. F.A. Davis, Philadelphia 1989.</li><li><a class="nounderline abstract_t">Harper C. The incidence of Wernicke's encephalopathy in Australia--a neuropathological study of 131 cases. J Neurol Neurosurg Psychiatry 1983; 46:593.</a></li><li><a class="nounderline abstract_t">Blansjaar BA, Van Dijk JG. Korsakoff minus Wernicke syndrome. Alcohol Alcohol 1992; 27:435.</a></li><li><a class="nounderline abstract_t">Freund G. Chronic central nervous system toxicity of alcohol. Annu Rev Pharmacol 1973; 13:217.</a></li><li><a class="nounderline abstract_t">Gregory MC, Hammond ME, Brewer ED. Renal deposition of cytomegalovirus antigen in immunoglobulin-A nephropathy. Lancet 1988; 1:11.</a></li><li><a class="nounderline abstract_t">Parkin AJ, Blunden J, Rees JE, Hunkin NM. Wernicke-Korsakoff syndrome of nonalcoholic origin. Brain Cogn 1991; 15:69.</a></li><li><a class="nounderline abstract_t">Pittella JE, de Castro LP. Wernicke's encephalopathy manifested as Korsakoff's syndrome in a patient with promyelocytic leukemia. South Med J 1990; 83:570.</a></li><li><a class="nounderline abstract_t">Engel PA, Grunnet M, Jacobs B. Wernicke-Korsakoff syndrome complicating T-cell lymphoma: unusual or unrecognized? South Med J 1991; 84:253.</a></li><li><a class="nounderline abstract_t">Cruickshank, EK. Wernicke's encephalopathy. Q J Med 1950; 19:327.</a></li><li><a class="nounderline abstract_t">Becker JT, Furman JM, Panisset M, Smith C. Characteristics of the memory loss of a patient with Wernicke-Korsakoff's syndrome without alcoholism. Neuropsychologia 1990; 28:171.</a></li><li><a class="nounderline abstract_t">Beatty WW, Bailly RC, Fisher L. Korsakoff-like amnesic syndrome in a patient with anorexia and vomiting. Int J Clin Neuropsychol 1988; 11:55.</a></li><li><a class="nounderline abstract_t">Eckardt MJ, Martin PR. Clinical assessment of cognition in alcoholism. Alcohol Clin Exp Res 1986; 10:123.</a></li><li><a class="nounderline abstract_t">Harding A, Halliday G, Caine D, Kril J. Degeneration of anterior thalamic nuclei differentiates alcoholics with amnesia. Brain 2000; 123 ( Pt 1):141.</a></li><li><a class="nounderline abstract_t">Pitel AL, Chételat G, Le Berre AP, et al. Macrostructural abnormalities in Korsakoff syndrome compared with uncomplicated alcoholism. Neurology 2012; 78:1330.</a></li><li><a class="nounderline abstract_t">Bowden SC. Separating cognitive impairment in neurologically asymptomatic alcoholism from Wernicke-Korsakoff syndrome: is the neuropsychological distinction justified? Psychol Bull 1990; 107:355.</a></li><li><a class="nounderline abstract_t">Torvik A, Lindboe CF, Rogde S. Brain lesions in alcoholics. A neuropathological study with clinical correlations. J Neurol Sci 1982; 56:233.</a></li><li><a class="nounderline abstract_t">Lishman WA. Alcoholic dementia: a hypothesis. Lancet 1986; 1:1184.</a></li><li><a class="nounderline abstract_t">Johnson JM, Fox V. Beyond Thiamine: Treatment for Cognitive Impairment in Korsakoff's Syndrome. Psychosomatics 2018; 59:311.</a></li><li><a class="nounderline abstract_t">Phillips BK, Ingram MV, Grammer GG. Wernicke-Korsakoff syndrome and galantamine. Psychosomatics 2004; 45:366.</a></li><li><a class="nounderline abstract_t">Cochrane M, Cochrane A, Jauhar P, Ashton E. Acetylcholinesterase inhibitors for the treatment of Wernicke-Korsakoff syndrome--three further cases show response to donepezil. Alcohol Alcohol 2005; 40:151.</a></li><li><a class="nounderline abstract_t">Rustembegović A, Kundurović Z, Sapcanin A, Sofic E. A placebo-controlled study of memantine (Ebixa) in dementia of Wernicke-Korsakoff syndrome. Med Arh 2003; 57:149.</a></li><li><a class="nounderline abstract_t">Martin PR, Adinoff B, Weingartner H, et al. Alcoholic organic brain disease: nosology and pathophysiologic mechanisms. Prog Neuropsychopharmacol Biol Psychiatry 1986; 10:147.</a></li><li><a class="nounderline abstract_t">Charness ME, Simon RP, Greenberg DA. Ethanol and the nervous system. N Engl J Med 1989; 321:442.</a></li><li><a class="nounderline abstract_t">Charness ME. Brain lesions in alcoholics. Alcohol Clin Exp Res 1993; 17:2.</a></li><li><a class="nounderline abstract_t">Carlen PL, Wortzman G, Holgate RC, et al. Reversible cerebral atrophy in recently abstinent chronic alcoholics measured by computed tomography scans. Science 1978; 200:1076.</a></li><li><a class="nounderline abstract_t">Carlen PL, Wilkinson DA, Wortzman G, Holgate R. Partially reversible cerebral atrophy and functional improvement in recently abstinent alcoholics. Can J Neurol Sci 1984; 11:441.</a></li><li><a class="nounderline abstract_t">Schroth G, Naegele T, Klose U, et al. Reversible brain shrinkage in abstinent alcoholics, measured by MRI. Neuroradiology 1988; 30:385.</a></li><li><a class="nounderline abstract_t">Zipursky RB, Lim KC, Pfefferbaum A. MRI study of brain changes with short-term abstinence from alcohol. Alcohol Clin Exp Res 1989; 13:664.</a></li><li><a class="nounderline abstract_t">Harper CG, Kril JJ, Daly JM. Brain shrinkage in alcoholics is not caused by changes in hydration: a pathological study. J Neurol Neurosurg Psychiatry 1988; 51:124.</a></li><li><a class="nounderline abstract_t">Harper C, Kril J, Daly J. Does a "moderate" alcohol intake damage the brain? J Neurol Neurosurg Psychiatry 1988; 51:909.</a></li><li><a class="nounderline abstract_t">Bartsch AJ, Homola G, Biller A, et al. Manifestations of early brain recovery associated with abstinence from alcoholism. Brain 2007; 130:36.</a></li><li><a class="nounderline abstract_t">Kril JJ, Halliday GM, Svoboda MD, Cartwright H. The cerebral cortex is damaged in chronic alcoholics. Neuroscience 1997; 79:983.</a></li><li><a class="nounderline abstract_t">Harper C, Kril J, Daly J. Are we drinking our neurones away? Br Med J (Clin Res Ed) 1987; 294:534.</a></li><li><a class="nounderline abstract_t">Adams KM, Gilman S, Koeppe RA, et al. Neuropsychological deficits are correlated with frontal hypometabolism in positron emission tomography studies of older alcoholic patients. Alcohol Clin Exp Res 1993; 17:205.</a></li><li><a class="nounderline abstract_t">Gilman S, Adams K, Koeppe RA, et al. Cerebellar and frontal hypometabolism in alcoholic cerebellar degeneration studied with positron emission tomography. Ann Neurol 1990; 28:775.</a></li><li><a class="nounderline abstract_t">Harper CG, Kril JJ, Holloway RL. Brain shrinkage in chronic alcoholics: a pathological study. Br Med J (Clin Res Ed) 1985; 290:501.</a></li><li><a class="nounderline abstract_t">Harper C. The neuropathology of alcohol-specific brain damage, or does alcohol damage the brain? J Neuropathol Exp Neurol 1998; 57:101.</a></li><li><a class="nounderline abstract_t">Jensen GB, Pakkenberg B. Do alcoholics drink their neurons away? Lancet 1993; 342:1201.</a></li><li><a class="nounderline abstract_t">de la Monte SM. Disproportionate atrophy of cerebral white matter in chronic alcoholics. Arch Neurol 1988; 45:990.</a></li><li><a class="nounderline abstract_t">Pfefferbaum A, Sullivan EV. Microstructural but not macrostructural disruption of white matter in women with chronic alcoholism. Neuroimage 2002; 15:708.</a></li><li><a class="nounderline abstract_t">Shear PK, Jernigan TL, Butters N. Volumetric magnetic resonance imaging quantification of longitudinal brain changes in abstinent alcoholics. Alcohol Clin Exp Res 1994; 18:172.</a></li><li><a class="nounderline abstract_t">Gazdzinski S, Durazzo TC, Mon A, et al. Cerebral white matter recovery in abstinent alcoholics--a multimodality magnetic resonance study. Brain 2010; 133:1043.</a></li><li><a class="nounderline abstract_t">Victor M, Adams RD, Mancall EL. A restricted form of cerebellar cortical degeneration occurring in alcoholic patients. Arch Neurol 1959; 1:579.</a></li><li><a class="nounderline abstract_t">MANCALL EL, MCENTEE WJ. ALTERATIONS OF THE CEREBELLAR CORTEX IN NUTRITIONAL ENCEPHALOPATHY. Neurology 1965; 15:303.</a></li><li><a class="nounderline abstract_t">Nicolás JM, Fernández-Solà J, Robert J, et al. High ethanol intake and malnutrition in alcoholic cerebellar shrinkage. QJM 2000; 93:449.</a></li><li><a class="nounderline abstract_t">Antunez E, Estruch R, Cardenal C, et al. Usefulness of CT and MR imaging in the diagnosis of acute Wernicke's encephalopathy. AJR Am J Roentgenol 1998; 171:1131.</a></li><li><a class="nounderline abstract_t">Del Brutto OH, Mera RM, Sullivan LJ, et al. Population-based study of alcoholic cerebellar degeneration: The Atahualpa Project. J Neurol Sci 2016; 367:356.</a></li><li><a class="nounderline abstract_t">Del Brutto OH, Mera RM, King NR, et al. Years of Drinking but Not the Amount of Alcohol Intake Contribute to the Association Between Alcoholic Cerebellar Degeneration and Worse Cognitive Performance. A Population-Based Study. Cerebellum 2017; 16:612.</a></li><li><a class="nounderline abstract_t">Hillbom M, Muuronen A, Holm L, Hindmarsh T. The clinical versus radiological diagnosis of alcoholic cerebellar degeneration. J Neurol Sci 1986; 73:45.</a></li><li><a class="nounderline abstract_t">Lee JH, Heo SH, Chang DI. Early-stage Alcoholic Cerebellar Degeneration: Diagnostic  Imaging Clues. J Korean Med Sci 2015; 30:1539.</a></li><li><a class="nounderline abstract_t">Gilman S, Koeppe RA, Adams K, et al. Positron emission tomographic studies of cerebral benzodiazepine-receptor binding in chronic alcoholics. Ann Neurol 1996; 40:163.</a></li><li><a class="nounderline abstract_t">Diener HC, Dichgans J, Bacher M, Guschlbauer B. Improvement of ataxia in alcoholic cerebellar atrophy through alcohol abstinence. J Neurol 1984; 231:258.</a></li><li class="breakAll">Brion, S. Marchiafava-Bignami syndrome. In: Metabolic and Deficiency Diseases of the Nervous System, Part 2, Vinken, PJ, Bruyn, GW (Eds), North-Holland Publishing Company, Amsterdam 1976. p.317.</li><li><a class="nounderline abstract_t">Rosa A, Demiati M, Cartz L, Mizon JP. Marchiafava-Bignami disease, syndrome of interhemispheric disconnection, and right-handed agraphia in a left-hander. Arch Neurol 1991; 48:986.</a></li><li class="breakAll">Warach, SJ, Charness, ME. Imaging the brain lesions of alcoholics. In: Neuroimaging: A Companion to Adams and Victor's Principles of Neurology, Greenberg, JO, (Ed), McGraw-Hill, New York 1994. p.503.</li><li><a class="nounderline abstract_t">Harper CG, Kril JJ. Corpus callosal thickness in alcoholics. Br J Addict 1988; 83:577.</a></li><li><a class="nounderline abstract_t">Estruch R, Nicolás JM, Salamero M, et al. Atrophy of the corpus callosum in chronic alcoholism. J Neurol Sci 1997; 146:145.</a></li><li><a class="nounderline abstract_t">Pfefferbaum A, Lim KO, Desmond JE, Sullivan EV. Thinning of the corpus callosum in older alcoholic men: a magnetic resonance imaging study. Alcohol Clin Exp Res 1996; 20:752.</a></li><li><a class="nounderline abstract_t">Monforte R, Estruch R, Valls-Solé J, et al. Autonomic and peripheral neuropathies in patients with chronic alcoholism. A dose-related toxic effect of alcohol. Arch Neurol 1995; 52:45.</a></li><li><a class="nounderline abstract_t">Nicolás JM, Estruch R, Antunez E, et al. Nutritional status in chronically alcoholic men from the middle socioeconomic class and its relation to ethanol intake. Alcohol Alcohol 1993; 28:551.</a></li><li><a class="nounderline abstract_t">Claus D, Eggers R, Engelhardt A, et al. Ethanol and polyneuropathy. Acta Neurol Scand 1985; 72:312.</a></li><li><a class="nounderline abstract_t">Estruch R, Nicolás JM, Villegas E, et al. Relationship between ethanol-related diseases and nutritional status in chronically alcoholic men. Alcohol Alcohol 1993; 28:543.</a></li><li><a class="nounderline abstract_t">Behse, F, Buchthal, F. Alcoholic neuropathy: Clinical, electrophysiological, and biopsy findings. Ann Neurol 1977; 2:95.</a></li><li><a class="nounderline abstract_t">Koike H, Mori K, Misu K, et al. Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status. Neurology 2001; 56:1727.</a></li><li><a class="nounderline abstract_t">Koike H, Iijima M, Sugiura M, et al. Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy. Ann Neurol 2003; 54:19.</a></li><li><a class="nounderline abstract_t">D'Amour ML, Bruneau J, Butterworth RF. Abnormalities of peripheral nerve conduction in relation to thiamine status in alcoholic patients. Can J Neurol Sci 1991; 18:126.</a></li><li><a class="nounderline abstract_t">Paladin F, Russo Perez G. The haematic thiamine level in the course of alcoholic neuropathy. Eur Neurol 1987; 26:129.</a></li><li><a class="nounderline abstract_t">Sosenko JM, Soto R, Aronson J, et al. The prevalence and extent of vibration sensitivity impairment in men with chronic ethanol abuse. J Stud Alcohol 1991; 52:374.</a></li><li><a class="nounderline abstract_t">Kemppainen R, Juntunen J, Hillbom M. Drinking habits and peripheral alcoholic neuropathy. Acta Neurol Scand 1982; 65:11.</a></li><li><a class="nounderline abstract_t">Villalta J, Estruch R, Antúnez E, et al. Vagal neuropathy in chronic alcoholics: relation to ethanol consumption. Alcohol Alcohol 1989; 24:421.</a></li><li><a class="nounderline abstract_t">Hawley RJ, Kurtzke JF, Armbrustmacher VW, et al. The course of alcoholic-nutritional peripheral neuropathy. Acta Neurol Scand 1982; 66:582.</a></li><li><a class="nounderline abstract_t">Hillbom M, Wennberg A. Prognosis of alcoholic peripheral neuropathy. J Neurol Neurosurg Psychiatry 1984; 47:699.</a></li><li><a class="nounderline abstract_t">Palliyath S, Schwartz BD. Peripheral nerve functions improve in chronic alcoholic patients on abstinence. J Stud Alcohol 1993; 54:684.</a></li><li><a class="nounderline abstract_t">Nishiyama K, Sakuta M. Mexiletine for painful alcoholic neuropathy. Intern Med 1995; 34:577.</a></li><li><a class="nounderline abstract_t">Urbano-Marquez A, Estruch R, Navarro-Lopez F, et al. The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med 1989; 320:409.</a></li><li><a class="nounderline abstract_t">Martin F, Ward K, Slavin G, et al. Alcoholic skeletal myopathy, a clinical and pathological study. Q J Med 1985; 55:233.</a></li><li><a class="nounderline abstract_t">Song SK, Rubin E. Ethanol produces muscle damage in human volunteers. Science 1972; 175:327.</a></li><li><a class="nounderline abstract_t">Sacanella E, Fernández-Solà J, Cofan M, et al. Chronic alcoholic myopathy: diagnostic clues and relationship with other ethanol-related diseases. QJM 1995; 88:811.</a></li><li><a class="nounderline abstract_t">Haller RG, Carter NW, Ferguson E, Knochel JP. Serum and muscle potassium in experimental alcoholic myopathy. Neurology 1984; 34:529.</a></li><li><a class="nounderline abstract_t">Preedy VR, Adachi J, Peters TJ, et al. Recent advances in the pathology of alcoholic myopathy. Alcohol Clin Exp Res 2001; 25:54S.</a></li><li><a class="nounderline abstract_t">Haller RG, Drachman DB. Alcoholic rhabdomyolysis: an experimental model in the rat. Science 1980; 208:412.</a></li><li><a class="nounderline abstract_t">Weber LD, Nashel DJ, Mellow MH. Pharyngeal dysphagia in alcoholic myopathy. Ann Intern Med 1981; 95:189.</a></li><li><a class="nounderline abstract_t">Rubin E. Alcoholic myopathy in heart and skeletal muscle. N Engl J Med 1979; 301:28.</a></li><li><a class="nounderline abstract_t">Urbano-Márquez A, Estruch R, Fernández-Solá J, et al. The greater risk of alcoholic cardiomyopathy and myopathy in women compared with men. JAMA 1995; 274:149.</a></li><li><a class="nounderline abstract_t">Fernández-Solá J, Sacanella E, Estruch R, et al. Significance of type II fiber atrophy in chronic alcoholic myopathy. J Neurol Sci 1995; 130:69.</a></li><li><a class="nounderline abstract_t">Estruch R, Sacanella E, Fernández-Solá J, et al. Natural history of alcoholic myopathy: a 5-year study. Alcohol Clin Exp Res 1998; 22:2023.</a></li><li><a class="nounderline abstract_t">Fernández-Solà J, Nicolás JM, Sacanella E, et al. Low-dose ethanol consumption allows strength recovery in chronic alcoholic myopathy. QJM 2000; 93:35.</a></li></ol></div><div id="topicVersionRevision">Topic 4840 Version 9.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Victor, M, Adams, RA, Collins, GH. The Wernicke-Korsakoff syndrome and related disorders due to alcoholism and malnutrition. F.A. Davis, Philadelphia 1989.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6886695" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The incidence of Wernicke's encephalopathy in Australia--a neuropathological study of 131 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1418116" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Korsakoff minus Wernicke syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4576890" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Chronic central nervous system toxicity of alcohol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2891887" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Renal deposition of cytomegalovirus antigen in immunoglobulin-A nephropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1901211" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Wernicke-Korsakoff syndrome of nonalcoholic origin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2188373" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Wernicke's encephalopathy manifested as Korsakoff's syndrome in a patient with promyelocytic leukemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1990464" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Wernicke-Korsakoff syndrome complicating T-cell lymphoma: unusual or unrecognized?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Wernicke's encephalopathy</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2314572" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Characteristics of the memory loss of a patient with Wernicke-Korsakoff's syndrome without alcoholism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Korsakoff-like amnesic syndrome in a patient with anorexia and vomiting</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3521368" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Clinical assessment of cognition in alcoholism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10611128" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Degeneration of anterior thalamic nuclei differentiates alcoholics with amnesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22496200" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Macrostructural abnormalities in Korsakoff syndrome compared with uncomplicated alcoholism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2190253" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Separating cognitive impairment in neurologically asymptomatic alcoholism from Wernicke-Korsakoff syndrome: is the neuropsychological distinction justified?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7175549" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Brain lesions in alcoholics. A neuropathological study with clinical correlations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2871423" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Alcoholic dementia: a hypothesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29751937" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Beyond Thiamine: Treatment for Cognitive Impairment in Korsakoff's Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15232056" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Wernicke-Korsakoff syndrome and galantamine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15596427" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Acetylcholinesterase inhibitors for the treatment of Wernicke-Korsakoff syndrome--three further cases show response to donepezil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12858653" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : A placebo-controlled study of memantine (Ebixa) in dementia of Wernicke-Korsakoff syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2875490" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Alcoholic organic brain disease: nosology and pathophysiologic mechanisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2668759" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Ethanol and the nervous system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8452204" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Brain lesions in alcoholics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/653357" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Reversible cerebral atrophy in recently abstinent chronic alcoholics measured by computed tomography scans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6518426" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Partially reversible cerebral atrophy and functional improvement in recently abstinent alcoholics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3211313" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Reversible brain shrinkage in abstinent alcoholics, measured by MRI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2688465" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : MRI study of brain changes with short-term abstinence from alcohol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3351512" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Brain shrinkage in alcoholics is not caused by changes in hydration: a pathological study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3204399" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Does a "moderate" alcohol intake damage the brain?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17178742" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Manifestations of early brain recovery associated with abstinence from alcoholism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9219961" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The cerebral cortex is damaged in chronic alcoholics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3103762" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Are we drinking our neurones away?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8488956" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Neuropsychological deficits are correlated with frontal hypometabolism in positron emission tomography studies of older alcoholic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2285264" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Cerebellar and frontal hypometabolism in alcoholic cerebellar degeneration studied with positron emission tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3918649" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Brain shrinkage in chronic alcoholics: a pathological study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9600202" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : The neuropathology of alcohol-specific brain damage, or does alcohol damage the brain?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7901529" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Do alcoholics drink their neurons away?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3415529" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Disproportionate atrophy of cerebral white matter in chronic alcoholics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11848714" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Microstructural but not macrostructural disruption of white matter in women with chronic alcoholism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8198216" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Volumetric magnetic resonance imaging quantification of longitudinal brain changes in abstinent alcoholics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20133395" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Cerebral white matter recovery in abstinent alcoholics--a multimodality magnetic resonance study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : A restricted form of cerebellar cortical degeneration occurring in alcoholic patients</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14280592" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : ALTERATIONS OF THE CEREBELLAR CORTEX IN NUTRITIONAL ENCEPHALOPATHY.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10874054" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : High ethanol intake and malnutrition in alcoholic cerebellar shrinkage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9763009" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Usefulness of CT and MR imaging in the diagnosis of acute Wernicke's encephalopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27423619" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Population-based study of alcoholic cerebellar degeneration: The Atahualpa Project.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27696290" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Years of Drinking but Not the Amount of Alcohol Intake Contribute to the Association Between Alcoholic Cerebellar Degeneration and Worse Cognitive Performance. A Population-Based Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3701368" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : The clinical versus radiological diagnosis of alcoholic cerebellar degeneration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26848494" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Early-stage Alcoholic Cerebellar Degeneration: Diagnostic  Imaging Clues.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8773597" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Positron emission tomographic studies of cerebral benzodiazepine-receptor binding in chronic alcoholics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6520618" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Improvement of ataxia in alcoholic cerebellar atrophy through alcohol abstinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6520618" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Improvement of ataxia in alcoholic cerebellar atrophy through alcohol abstinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1953424" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Marchiafava-Bignami disease, syndrome of interhemispheric disconnection, and right-handed agraphia in a left-hander.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1953424" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Marchiafava-Bignami disease, syndrome of interhemispheric disconnection, and right-handed agraphia in a left-hander.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3382816" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Corpus callosal thickness in alcoholics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9077511" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Atrophy of the corpus callosum in chronic alcoholism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8800395" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Thinning of the corpus callosum in older alcoholic men: a magnetic resonance imaging study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7826275" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Autonomic and peripheral neuropathies in patients with chronic alcoholism. A dose-related toxic effect of alcohol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8274179" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Nutritional status in chronically alcoholic men from the middle socioeconomic class and its relation to ethanol intake.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2998144" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Ethanol and polyneuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8274178" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Relationship between ethanol-related diseases and nutritional status in chronically alcoholic men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Alcoholic neuropathy: Clinical, electrophysiological, and biopsy findings</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11425941" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12838517" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2070293" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Abnormalities of peripheral nerve conduction in relation to thiamine status in alcoholic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3032641" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : The haematic thiamine level in the course of alcoholic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1652043" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : The prevalence and extent of vibration sensitivity impairment in men with chronic ethanol abuse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6278809" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Drinking habits and peripheral alcoholic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2818751" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Vagal neuropathy in chronic alcoholics: relation to ethanol consumption.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6293240" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : The course of alcoholic-nutritional peripheral neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6086844" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Prognosis of alcoholic peripheral neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8271803" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Peripheral nerve functions improve in chronic alcoholic patients on abstinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7549147" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Mexiletine for painful alcoholic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2913506" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : The effects of alcoholism on skeletal and cardiac muscle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2991970" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Alcoholic skeletal myopathy, a clinical and pathological study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5008161" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Ethanol produces muscle damage in human volunteers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8542266" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Chronic alcoholic myopathy: diagnostic clues and relationship with other ethanol-related diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6538310" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Serum and muscle potassium in experimental alcoholic myopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11391050" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Recent advances in the pathology of alcoholic myopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7189294" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Alcoholic rhabdomyolysis: an experimental model in the rat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6789739" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Pharyngeal dysphagia in alcoholic myopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/377072" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Alcoholic myopathy in heart and skeletal muscle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7596003" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : The greater risk of alcoholic cardiomyopathy and myopathy in women compared with men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7650533" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Significance of type II fiber atrophy in chronic alcoholic myopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9884146" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Natural history of alcoholic myopathy: a 5-year study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10623780" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Low-dose ethanol consumption allows strength recovery in chronic alcoholic myopathy.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
